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Shiga toxin (STx), produced by Shigella dysenteriae, and the
virtually identical Shiga-like toxins (SLTx) from
enterohemorrhagic strains of Escherichia coli, are A-B toxins,
in which a catalytically active A-subunit interacts with, in this
case, five receptor-binding B-fragments forming the homo-
pentameric B-subunit (STxB). The A-subunits of these toxins
have N-glycanase activity that inhibits protein synthesis
through a specific depurination of the large ribosomal RNA
(Endo et al., 1988). STx is associated with bacillary dysentery
whereas the SLTx proteins have a role in the pathological
manifestations of hemorrhagic colitis and haemolytic uremic
syndrome, a leading causes for pediatric renal failure (Peacock
et al., 2001). Other members of the A-B protein toxin family
include cholera toxin (CTx), ricin, E. coli heat-labile
enterotoxin, and Pseudomonas exotoxin A, which, like
STx/SLTx, reach their cytosolic targets by retrotranslocation
from the lumen of the endoplasmic reticulum (ER) (Lord et al.,
2003).
STxB is responsible for high-affinity binding to the toxin’s
cell surface receptor globotriaosyl ceramide (Gb3/CD77)
(Lingwood, 1993), and for subsequent internalization. From
early endosomes/recycling endosomes (EEs/REs), STxB has
been described to leave the endocytic pathway (Mallard et al.,
1998) and to be targeted to the ER (Johannes et al., 1997;
Sandvig et al., 1992) via the Golgi complex (for reviews, see
Johannes and Decaudin, 2005; Sandvig et al., 2004; Smith et
al., 2004). For reasons such as the abundance of its cellular
receptor and the possibility to synchronize its cellular uptake
at the plasma membrane and the EE/RE, STxB has turned out
to be a suitable marker for studying retrograde transport, and
innovative quantitative and morphological tools have been
developed to this end (reviewed in Amessou et al., 2007;
Mallard and Johannes, 2003; Tai et al., 2005).
The molecular machinery underlying the newly described
transport step from the EE/RE to the trans-Golgi network
(TGN) is currently being identified. Retrograde sorting of
STxB from EE/RE depends on clathrin (Lauvrak et al., 2004;
Saint-Pol et al., 2004) and the putative clathrin adaptor epsinR
(Saint-Pol et al., 2004). It also involves membrane
microdomain organization (Falguières et al., 2001) and
GPP130 (Natarajan and Linstedt, 2004), a Golgi protein of
unknown function. Targeting and fusion of EE/RE-derived,
STxB-containing transport intermediates with Golgi/TGN
membranes is regulated by the small GTPase Rab6a’, the
putative TGN tethering molecule golgin-97 (Lu et al., 2004),
and by two soluble N-ethylmaleimide-sensitive fusion protein
attachment protein receptor (SNARE) complexes that include
the heavy-chain tSNAREs syntaxin 16 (Mallard et al., 2002)
and syntaxin 5 (Tai et al., 2004).
Retrograde transport allows proteins and lipids to leave the
endocytic pathway to reach other intracellular
compartments, such as trans-Golgi network (TGN)/Golgi
membranes, the endoplasmic reticulum and, in some
instances, the cytosol. Here, we have used RNA interference
against the SNARE proteins syntaxin 5 and syntaxin 16,
combined with recently developed quantitative trafficking
assays, morphological approaches and cell intoxication
analysis to show that these SNARE proteins are not only
required for efficient retrograde transport of Shiga toxin,
but also for that of an endogenous cargo protein – the
mannose 6-phosphate receptor – and for the productive
trafficking into cells of cholera toxin and ricin. We have
found that the function of syntaxin 16 was specifically
required for, and restricted to, the retrograde pathway.
Strikingly, syntaxin 5 RNA interference protected cells
particularly strongly against Shiga toxin. Since our
trafficking analysis showed that apart from inhibiting
retrograde endosome-to-TGN transport, the silencing of
syntaxin 5 had no additional effect on Shiga toxin
endocytosis or trafficking from TGN/Golgi membranes to
the endoplasmic reticulum, we hypothesize that syntaxin 5
also has trafficking-independent functions. In summary,
our data demonstrate that several cellular and exogenous
cargo proteins use elements of the same SNARE machinery
for efficient retrograde transport between early/recycling
endosomes and TGN/Golgi membranes.
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SNAREs are trans-membrane proteins that are essential for
membrane fusion and that contribute to the specificity of this
process (Chen and Scheller, 2001; Jahn and Grubmuller, 2002;
Pelham and Rothman, 2000). These functions are driven by a
specific pairing of four coiled-coil domains contributed by a
VAMP (vesicle or R-SNARE), a syntaxin (target or Qa
SNARE) and one or two proteins that contribute two coiled-
coils (Qb-Qc SNAREs). Several SNARE proteins have been
described that can be found within Golgi membranes (Chen
and Scheller, 2001). These include five syntaxins: syntaxin 5
(Bennett et al., 1993; Hay et al., 1998), syntaxin 6 (Bock et al.,
1996), syntaxin 10 (Tang et al., 1998b), syntaxin 11 (Valdez et
al., 1999) and syntaxin 16 (Tang et al., 1998a). The two
syntaxins involved in retrograde transport to the TGN –
syntaxin 5 (Syn5) and syntaxin 16 (Syn16) – are found in
different SNARE complexes: Syn16 associates with syntaxin
6 and Vti1a to form a tSNARE complex at the TGN whose
physical and functional interaction with the endosomal
vSNARE VAMP4 and – to a lesser extent – with VAMP3,
regulates retrograde transport (Mallard et al., 2002). Syn5 has
been described in two different molecular environments, one
as part of a Syn5-GS27-Sec22-Bet1 complex at the cis-
Golgi–ER interface (Hay et al., 1998), and the other as a
component of a Syn5-GS28-Ykt6-GS15 complex on Golgi
membranes (Hay et al., 1998; Xu et al., 2002). The latter
complex has been ascribed a role in retrograde transport to the
TGN (Tai et al., 2004).
The discovery of at least two SNARE complexes that are
involved in retrograde transport at the EE/RE-TGN interface
raises a number of questions, including whether these
complexes have cargo-specific functions. It has already been
shown that Syn16 function is required for the retrograde
trafficking of STxB, the cellular protein TGN38/46 of
unknown function, and the mannose 6-phosphate receptor
(MPR), which shuttles lysosomal enzymes between TGN and
endosomes/lysosomes (Mallard et al., 2002; Saint-Pol et al.,
2004). Syn5 functions in the retrograde trafficking of STxB
(Tai et al., 2004). In the comparative study here, we have
chosen to inhibit Syn5 and Syn16 functions in HeLa cells by
RNA interference (RNAi) to silence their expression. Using
protein sulfation methodology (Amessou et al., 2007; Mallard
and Johannes, 2003) in combination with cell intoxication
assays and immunofluorescence, we have analyzed the
retrograde traffic of the endogenous cargo protein MPR, and
three exogenous cargoes, STxB, cholera toxin B-subunit
(CTxB) and ricin, under RNAi conditions. We report that the
intracellular transport of all these proteins was similarly
sensitive to an interference with Syn5 and Syn16 expression.
In the case of Syn16, the RNAi effect was highly selective for
retrograde transport in that transferrin recycling, transport and
degradation of epidermal growth factor (EGF) in lysosomes,
and biosynthetic/secretory VSV-G transport to the plasma
membrane were not affected. Surprisingly, when cytotoxicity
rather than retrograde transport was monitored, we discovered
that RNAi targeting Syn5 disrupted intoxication most strikingly
when cells were challenged with STx. RNAi against a further
member of the Golgi/TGN Syn5 SNARE complex, GS15, did
not produce this strong protective phenotpye. These
observations suggest that knockdown of Syn5 levels limits the
activity of a STx-specific factor required not for transport, but
in a downstream step following initial delivery of this toxin
into the ER lumen. Apart from this difference, it is clear from
our study that several exogenous and endogenous markers
share the same SNARE machinery for efficient retrograde
transport from endosomes to Golgi/TGN membranes.
Results
Specific inhibition of retrograde transport of STxB in
Syn16 RNAi conditions
Our previous studies have implicated Syn16 in retrograde
transport to the TGN as part of a soluble N-ethylmaleimide-
sensitive fusion protein attachment protein receptor (SNARE)
complex composed of Syn16, syntaxin 6, Vti1a, and the
vSNAREs VAMP4 or VAMP3 (Mallard et al., 2002). However,
in this earlier report, a functional requirement for Syn16 in
retrograde transport was not addressed. Using RNAi, we show
here that, in agreement with some recent studies (Smith et al.,
2006b; Wang et al., 2005), Syn16 is indeed required. Three
different small interfering RNA (siRNA) duplexes down-
modulated Syn16 expression (Fig. 1A, inset). We then used
sulfation analysis to quantify arrival of STxB in TGN/Golgi
membranes under these conditions. This assay exploits TGN-
localized sulfotransferase activity (Johannes et al., 1997;
Mallard et al., 1998); detailed in Mallard and Johannes
(Mallard and Johannes, 2003). Upon retrograde transport to the
TGN of the sulfation site-tagged STxB variant STxB-Sulf2,
tyrosyl sulfotransferase catalyzes addition of radioactive
sulfate, and following immunoprecipitation, sulfated STxB-
Sulf2 is detected and quantified by electrophoresis and
autoradiography. Transfection of the three anti-Syn16 siRNAs
led in all cases to an inhibition of retrograde transport, when
compared to mock (set to 100%) or scrambled siRNA-
transfected control cells (Fig. 1A). The specificity of the RNAi
effect was further demonstrated by showing a dose-dependency
of retrograde transport inhibition, using siRNA sequence 3
(Fig. 1B).
Immunofluorescence analysis was used to analyze the site
of STxB accumulation in Syn16 RNAi cells. In control cells
(Fig. 1C), STxB (green) was efficiently transported to
TGN/Golgi membranes and colocalized with the Golgi
cisternal marker CTR433 (red). In the same cells,
immunolabeled Syn16 (blue) was readily detected in co-
distribution with CTR433. By contrast, in siRNA-transfected
cells (Fig. 1D,E), the Syn16 signal (blue) was clearly
decreased. STxB (green) was detectable in peripheral
structures that were also positive for the transferrin receptor
(TfR; red, Fig. 1E), a marker of EE/RE. It was noticeable that
in Syn16 RNAi cells, STxB (green) also remained concentrated
in a perinuclear localization close to the Golgi complex
(CTR433; red, Fig. 1D). Whether STxB was actually in Golgi
cisternae, because of incomplete inhibition of retrograde
transport, or whether it accumulated close to Golgi cisternae
could not be distinguished at this level of resolution. Of note,
in Syn16 RNAi cells, was the perinuclear localization of TfR,
something normally not evident in HeLa cells (Lin et al.,
2002). In addition, in some cells, TfR-positive tubules
emanated from the perinuclear site, which also contained STxB
(Fig. 1E).
We tested the specificity of the Syn16 RNAi effect on
retrograde transport using three markers that traffic through
organelles constituting the EE/RE-TGN interface. In
interaction with its receptor, epidermal growth factor (EGF) is
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internalized by clathrin-dependent endocytosis into EE and
targeted to late endosomes/lysosomes for degradation (Wiley
and Burke, 2001). We found here that degradation of this
protein, as measured by the appearance of acid soluble counts
in the cell culture medium (Mallard et al., 1998), was largely
unaffected in Syn16 RNAi cells (Fig. 1F). This suggested that
trafficking through the endocytic pathway was functionally
unperturbed. Next, we observed that transferrin (Tf) recycling
from EE/RE back to the plasma membrane was similar in
control and Syn16 RNAi cells (Fig. 1G). Finally, a model
cargo, the vesicular stomatitis virus glycoprotein (VSVG), was
used to assess the effect of Syn16 RNAi on anterograde
trafficking along the biosynthetic/secretory pathway to the
plasma membrane, via the TGN (Fig. 1H). Again, no difference
in trafficking was observed. The validity of the assay was
confirmed by showing that brefeldin A (BFA) could totally
inhibit the transport of VSVG (Fig. 1H, right column). We also
demonstrated that cell surface binding sites and apparent
Fig. 1. Specific inhibition of
retrograde transport of STxB in Syn16
RNAi conditions. (A) Metabolic
sulfation of internalized STxB-Sulf2
on HeLa cells over a 20-minute period
was visualized by
immunoprecipitation from cells that
had been transfected for 72 hours with
three different siRNAs against Syn16
or with scrambled (Sc) siRNA (200
nM each). Data are expressed as
percentages of STxB-Sulf2 sulfation
for each experimental condition, using
sulfation of STxB-Sulf2 on mock-
transfected cells as the reference (set
to 100%), and normalized for total
sulfation counts (see Materials and
Methods and Fig. 2C). Inset: Western
blotting confirmed the down-
modulation of Syn16 under these
conditions. Tubulin was used as a
loading control. (B) Sulfation analysis
(as in A) of STxB-Sulf2 applied to
HeLa cells that had been transfected
for 72 hours with increasing doses of
anti-Syn16 siRNA number 3. Inset:
Western blot of Syn16 under the
indicated conditions.
(C-E) Immunofluorescence analysis of
retrograde STxB transport in (C)
mock-transfected control (CTL) and
(D-E) Syn16 RNAi cells (siRNA
sequence number 3 at 200 nM). In all
conditions fluorophore-labeled STxB
(green) was internalized for 45
minutes at 37°C. Cells were fixed and
labeled for Syn16 (blue), the Golgi
marker CTR433 (red, D), or TfR (red,
E). Under Syn16 RNAi conditions,
STxB accumulation in the Golgi was
reduced, and the protein appeared in
peripheral structures where it co-
distributed with the TfR. Bar, 10 m.
(F-H) Specificity controls for the
Syn16 RNAi. (F) EGF degradation.
2.5 ng/ml of iodine-labeled EGF was
incubated for the indicated times with
HeLa cells in the indicated conditions.
Lysosomal degradation was measured
by appearance of TCA-soluble counts
in the culture medium (G) Tf recycling. Biotin-tagged Tf was internalized at 37°C for 40 minutes into HeLa cells in the indicated conditions.
Cells were washed and further incubated as shown at 37°C. Remaining cell-associated Tf was determined by ELISA. In F-G, the means of three
to four independent experiments are shown. (H) VSVG transport in the biosynthetics/secretory pathway. The trafficking of newly synthesized
VSVG-ts045 to the plasma membrane was analyzed by cell-surface biotinylation after a shift in temperature from 40°C to 32°C. BFA was used













affinity of STxB for cells were not altered in Syn16 RNAi cells,
when compared with mock-transfected control cells (Table 1).
Taken together, these data demonstrate that Syn16 is
specifically required for efficient retrograde STxB transport
from EE/RE to the TGN.
Specific function of Syn5 in the EE/RE-to-TGN transport
step of the retrograde pathway
In addition to the Syn16-containing SNARE complexes
(Mallard et al., 2002), Syn5 and GS15 have recently been
identified as further molecular players at the EE/RE-TGN
interface (Tai et al., 2004). We used siRNAs as described by
Hong and colleagues (Tai et al., 2004) and developed new ones
that allowed robust knock down of Syn5 and GS15 (Fig. 2A).
We also showed that down-modulating Syn16 expression had
no effect on Syn5, and vice versa (Fig. 2A, lower panels),
suggesting that loss of one complex is not compensated by the
upregulation of the other one. Monitoring sulfation, we found
that Syn5 and GS15 RNAi induced a strong inhibition of
retrograde transport of STxB, when compared with mock-
transfected control cells (set to 100%) or scrambled siRNA-
transfected cells (Fig. 2B). The levels of inhibition were similar
to those observed with Syn16 RNAi (Fig. 2B). To control for
specificity, we showed that RNAi targeting the late endosomal
tSNARE Syn7 did not affect retrograde transport of STxB (Fig.
2B), despite efficient down-modulation of the Syn7 target
protein (Fig. 2A). Similarly, interfering with the function of the
TGN-localized tSNARE Syn10 did not prevent STxB from
reaching TGN membranes (Wang et al., 2005). The analysis of
sulfation signals on endogenous proteins revealed that these
were partially affected in the Syn5 RNAi condition (Fig. 2C),
suggesting that Golgi/TGN integrity was altered under these
conditions. Note that the inhibition data shown in Fig. 2B were
normalized to take account of the overall decrease in the
endogenous sulfation capacity (see Materials and Methods).
Immunofluorescence was used to study compartment
integrity and STxB accumulation sites under Syn5 RNAi
conditions. In mock-transfected control cells, STxB (green)
colocalized with Syn5 (blue) on CTR433-positive (red) Golgi
membranes after 45 minutes of internalization into HeLa cells
at 37°C (Fig. 2D). In Syn5 RNAi cells (Fig. 2E,F; low Syn5
signal, blue), STxB (green) accumulated in peripheral
structures that were distinct from Golgi cisternae (Fig. 2E, red)
and co-distributed with TfR (Fig. 2F, red; see inset). In these
cells, we observed a variable degree of Golgi disruption (Fig.
2E, CTR433, red), as reported in another recent study (Suga et
al., 2005), that probably reflects a complex role of Syn5 in
membrane trafficking from and to the Golgi cisternae (Dascher
et al., 1994; Hay et al., 1997; Tai et al., 2004). However, Syn5
RNAi did not appear to influence the presence of Gb3
molecules at the cell surface – as judged from Scatchard
analysis, which revealed equal numbers of STxB cell surface
binding sites on mock-transfected control cells and Syn5 RNAi
cells (Table 1).
In the light of the endogenous sulfation phenotype (Fig. 2C)
and the effect on Golgi morphology (Fig. 2E), we sought to
have an independent confirmation of the inhibitory effect of
Syn5 RNAi on retrograde STxB trafficking. For this, we used
a previously developed N-glycosylation-site-tagged STxB
variant, which becomes modified by oligosaccharyl transferase
upon arrival in the ER (Johannes et al., 1997; Mallard and
Johannes, 2003). When compared with mock-transfected
control cells, glycosylation was inhibited under Syn5, GS15
and Syn16 RNAi conditions (Fig. 3A), strongly suggesting that
retrograde arrival in the ER was delayed in all cases. Strikingly,
the level of inhibition was similar in all conditions (Fig. 3A),
as seen for arrival in TGN/Golgi membranes (Fig. 2B). This
suggested that, of all possible retrograde transport steps, only
EE/RE-to-TGN trafficking was inhibited, despite the effect on
Golgi morphology, which was specific for Syn5 RNAi cells.
This prediction was tested directly, as shown below.
The first step of retrograde transport to the ER is
endocytosis. We showed that neither the uptake of STxB (Fig.
3B) nor that of Tf (Fig. 3C) were affected in Syn5 RNAi cells.
After leaving the endosome via the EE/RE-TGN interface,
STxB is then transported from TGN/Golgi membranes to the
ER. We used another variant of STxB, termed STxB-Sulf-
Glyc-KDEL, to analyze this transport process. Treating HeLa
cells with this protein in the presence of radioactive sulfate
leads to its metabolic labeling in the TGN. Thereafter,
glycosylation of the sulfated STxB-Sulf-Glyc-KDEL can be
measured to signify arrival in the ER. Since glycosylation
analysis is a relative measure – i.e. it determines the fraction
of sulfated STxB-Sulf-Glyc-KDEL that is also glycosylated –
it is independent of differences in sulfation efficiency between
experimental conditions and can thus report on events at the
TGN/Golgi-ER interface even if the preceding EE/RE-TGN
interface is affected.
Under control conditions, i.e. after 2 hours incubation of
STxB-Sulf-Glyc-KDEL with mock-transfected cells in the
presence of radioactive sulfate (pulse) followed by a 4-hour
chase, a complex pattern of bands was observed by
glycosylation analysis (Fig. 3D). The uppermost band (1)
represents the glycosylation product, as judged from its
electrophoretic mobility and the fact that it selectively
disappeared upon tunicamycin treatment. The second band
(2) corresponds to a TGN-sulfated but non-glycosylated
STxB-Sulf-Glyc-KDEL. The third band (3) represents a
proteolytic cleavage product of the TGN-sulfated STxB-Sulf-
Glyc-KDEL still containing the glycosylation sequence.
Indeed, this band became selectively intensified upon
tunicamycin treatment. Bands 4-6 represent further
proteolytic cleavage products on which the glycosylation
sequence was removed. STxB-Sulf2 is shown on the right of
Fig. 3D for comparison. We observed that the pattern of
bands remained unchanged when Syn5 or GS15 expression
was down-modulated by RNAi, even though all bands were
weaker under Syn5 or GS15 RNAi conditions (Fig. 3D),
reflecting the inhibition of EE/RE-to-TGN transport
described above. Importantly, the quantitative analysis
Journal of Cell Science 120 (8)
Table 1. Scatchard analysis on cells in the indicated
control and RNAi conditions
Mock-transfected siSyn5 siSyn16
Kd (nM) 54 28 47
Binding sites (108) per cell 2.8 3.0 2.9
HeLa cells were mock-transfected or transfected with siRNAs at 200 nM
against the indicated proteins. Three days after transfection, the cells were
placed on ice and Scatchard analysis was performed as described previously












1461Cargos in the retrograde route
revealed that under all conditions, the same fraction of
sulfated STxB-Sulf-Glyc-KDEL became glycosylated (Fig.
3E), strongly suggesting that ER entry following retrograde
transport from TGN/Golgi membranes was not affected in all
cases. In summary, despite a profound effect on Golgi
morphology, Syn5 RNAi only led to an inhibition of EE/RE-
to-TGN transport of STxB, without affecting its
internalization or trafficking from TGN/Golgi membranes to
the ER.
A common fusion machinery in the retrograde route of
several cargo proteins
We then used the RNAi tools we had developed to find out
whether the same protein machinery is used for the efficient
targeting of different exogenous and endogenous cargo
proteins from endosomes to TGN/Golgi membranes. To
address this question, we have extended the STxB-based
sulfation assay to other cargo proteins, similar to what has been
described for ricin (Rapak et al., 1997). Three types of
Fig. 2. Effect of Syn5 RNAi on cell entry by STxB. (A) Western blot analysis of target-protein expression under variable RNAi conditions.
Note that, for Syn5, two different isoforms of the protein were detected. Sc,scrambled. (B) Sulfation was monitored over 20 minutes following
addition of STxB-Sulf2 to HeLa cells that had been transfected for 72 hours with 200 nM scrambled siRNA or siRNAs targeting the indicated
proteins. For Syn5, two independent siRNA sequences were used that gave similar results. For Syn16, sequence number 3 was used. Data are
expressed as percentages of STxB-Sulf2 sulfation for each experimental condition, using sulfation of STxB-Sulf2 on mock-transfected cells as
the reference (set to 100%), and normalized for total sulfation counts (see C). RNAi against the late endosomal Syn7 was taken as a specificity
control. Mean ± s.e.m. of three to five determinations are shown. (C) Sulfation levels on endogenous proteins under the indicated experimental
conditions. (D-F) Immunofluorescence analysis of retrograde STxB transport in (D) mock-transfected control (CTL) or (E-F) Syn5 RNAi cells.
In all conditions, fluorophore-labeled STxB (green) was internalized for 45 minutes at 37°C. Cells were fixed and labeled for Syn5 (blue), the
(D-E) Golgi marker CTR433 (red), or (F) TfR (red). Under Syn5 RNAi conditions, STxB accumulation in the Golgi was reduced, and the
protein appeared in peripheral structures where it co-distributed with TfR. Note that Golgi membranes were partly dispersed in (E) Syn5 RNAi













sulfation-site modifications were used (Fig. 4A). In the original
configuration, a dimer of sulfation sites was genetically fused
to STxB, yielding STxB-Sulf2 (Mallard et al., 1998). We have
now developed a protocol for the chemical coupling of a
sulfation-site peptide to CTxB or to an antibody directed
against green fluorescent protein (GFP) (reviewed in Amessou
et al., 2007). In the latter case, sulfation analysis is performed
on HeLa cells that stably express MPR300 fused to luminal
oriented GFP (Waguri et al., 2003). The anti-GFP is taken up
in association with GFP-MPR and undergoes retrograde
transport from the plasma membrane to the TGN.
Mass spectroscopy analysis permitted estimation of the
CTxB modification to approximately two sulfation peptides per
CTxB pentamer (not shown). Because of its size, this analysis
was not performed on anti-GFP antibody. Sulfation analysis
revealed that CTxB and MPR constructs were indeed sulfated
in HeLa cells (Fig. 4B). Due to the reduced labeling efficiency
of CTxB-Sulf2 and the sulfation-site-peptide-modified anti-
GFP-MPR antibody, retrograde transport was sampled for 40
minutes, and not for 20 minutes, as above. This sulfation was
inhibited by brefeldin A (BFA) (Fig. 4B), confirming that it
depended on retrograde transport (Mallard et al., 1998). These
experiments, like those reported below, were performed on a
HeLa-cell clone in which the STxB receptor Gb3 is uniformly
expressed throughout the cell population and which has high
levels of the CTxB receptor GM1.
In experiments in which the different markers were tested in
a pair-wise manner on the same cells, it was found that
retrograde transport to the TGN of CTxB and MPR was inhibited
to a similar extent to that of STxB in Syn16 (Fig. 4C) or Syn5
(Fig. 4D) RNAi cells. These data reveal that these different
exogenous and endogenous cargo proteins share a Syn5- and
Syn16-based machinery for efficient retrograde transport.
Immunofluorescence analysis showed that in Syn16 (Fig.
5A) or Syn5 (Fig. 5B) RNAi cells, STxB (red) and CTxB
(green) were both blocked in perfect overlap in peripheral
endosomes. These observations further support the contention
that STxB and CTxB use the same route to traffic between
endosomes and the TGN. Their binding to cells appears to be
independent, though, because it could be shown that CTxB
does not compete with radiolabeled STxB for binding to cells
(Fig. 5C). As a control, the efficient competition of unlabeled
STxB was demonstrated. Furthermore, the quantification of
STxB- and CTxB-positive cells in our HeLa-cell culture
Journal of Cell Science 120 (8)
Fig. 3. Analysis of endocytosis and TGN/Golgi-to-ER transport in
Syn5 RNAi cells. (A) Glycosylation analysis. Iodinated STxB-Glyc-
KDEL was incubated with mock-transfected or RNAi-transfected
HeLa cells for 4 hours. The percentage of glycosylated STxB-Glyc-
KDEL was determined from gels, as described (Johannes et al.,
1997; Mallard and Johannes, 2003). Glycosylation of STxB-Glyc-
KDEL in mock-transfected cells was taken as the maximal possible
(100%) value. Mean ± s.e.m. of two to three experiments. (B,C) The
endocytosis of (B) STxB and (C) Tf was determined on the same
cells. Data represent the percentage of cell-surface inaccessible
biotin-tagged STxB or Tf at each time point. Mean ± s.e.m. of four
experiments. (D,E) Quantitative analysis of TGN/Golgi-to-ER
transport. (D) STxB-Sulf-Glyc-KDEL was internalized into mock-
transfected (± tunicamycin) or siRNA-transfected HeLa cells for 2
hours in the presence of radioactive sulfate and then chased for 4
hours at 37°C. Cells were lysed, STxB-Sulf-Glyc-KDEL
immunoprecipitated and analyzed by SDS-PAGE. The uppermost
band (1) corresponds to the glycosylation product which disappears
upon tunicamycin treatment. See text for details. (E) Quantitative
analysis by Phosphoimager of the mean of two to three experiments
± s.e.m., as shown in D. Data express the percentages of sulfated
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system revealed that Gb3 and GM1 expression appear to be
largely independent (Fig. 5D).
Intoxication analysis under Syn5 and Syn16 RNAi
conditions
In the next experimental series, we analyzed how intoxication
of cells with STx, CTx and ricin was affected by the presence
of reduced levels of Syn5 or Syn16. Under conditions of Syn16
down-modulation, HeLa cells were partly protected against
intoxication by Shiga toxin (STx) (Fig. 6A). In these
experiments, the effect on protein synthesis of adding
increasing concentrations of STx to cells was measured. It was
observed that in Syn16 RNAi cells, higher doses of STx were
needed to obtain the same level of protein synthesis inhibition
as in mock-transfected control cells. Indeed, the IC50 was
shifted from 0.12 ng/ml in mock-transfected cells to 0.37 ng/ml
in Syn16 RNAi cells (3.1-fold protection). These data clearly
indicate that efficient retrograde transport is required for
efficient toxin arrival in the cytosol. The specificity of the effect
was documented by the finding that diphtheria toxin, which
translocated across the membrane of early endosomes
(Lemichez et al., 1997) and does not depend on the retrograde
pathway to intoxicate cells (Yoshida et al., 1991), could inhibit
protein biosynthesis efficiently under Syn16 RNAi conditions
(not shown).
Unexpectedly, we observed that Syn5 RNAi protected cells
more against STx than Syn16 RNAi (Fig. 6A), shifting the IC50
to 37.6 ng/ml for Syn5 RNAi cells (313-fold protection). This
effect was specific for Syn5, because reducing the levels of
GS15 resulted in an IC50 of 0.53 ng/ml (Fig. 6B; 4.4-fold
protection), analogous to the outcome of lowering endogenous
Syn16. When used in combination, the effect of Syn5-Syn16
RNAi (IC50 of 38.4 ng/ml, 320-fold protection; Fig. 6B) was
no different to that of Syn5 RNAi alone. These observations
showed that, despite their similar effects on retrograde
transport to TGN/Golgi membranes – as measured by the
analysis of sulfation (Fig. 2B) and glycosylation (Fig. 3A),
reduced levels of Syn5 and Syn16 had very different effects on
cell intoxication by STx.
To further characterize the effect of Syn5 and Syn16 RNAi
on the action of toxins routed via the TGN/Golgi and ER, we
tested both CTx and ricin. The A1 subunit of CTx acts as an
ADP-ribosyltransferase and catalyzes the transfer of an ADP-
ribose to the -chain of GS heterodimeric G-proteins (De Haan
and Hirst, 2004). This stabilizes the GTP bound form of Gs,
lowering its GTPase activity and thereby creating a constitutive
signal for the activation of adenylyl cyclase, leading to an
Fig. 4. Retrograde transport of different cargo proteins in Syn5 RNAi
and Syn16 RNAi cells. (A) Constructs used for sulfation analysis. A
genetic fusion of STxB with tandem sulfation sites was made as
described (Mallard et al., 1998). For CTxB, a tandem-sulfation-site
peptide was chemically coupled to primary amines. In the case of
MPR, the tandem-sulfation-site peptide was chemically coupled to
an anti-GFP antibody recognizing MPR-GFP protein in stably
transfected HeLa cells (Waguri et al., 2003). (B) Sulfation analysis of
sulfation-site -peptide-coupled CTxB and MPR. HeLa cells were
incubated for 40 minutes with the indicated proteins in the presence
of radioactive sulfate with or without BFA, followed by
immunoprecipitation and autoradiography. For CTxB, the arrow
indicates sulfated toxin-B subunit, whereas the upper bands, visible
under conditions with or without BFA, originate from contaminating
endogenous sulfoproteins at the level of the load. (C,D) STxB-Sulf2,
CTxB-Sulf2 and sulfation-site-coupled anti-GFP-MPR antibody
were incubated for 40 minutes in the presence of radioactive sulfate
with HeLa cells that had been transfected with (C) Syn16 siRNA
number 3 or (D) Syn5 siRNA number 1. Sulfated proteins were
immunoprecipitated and analyzed by SDS-PAGE and
autoradiography. Sulfation signals are expressed as normalized













elevation of cellular cAMP levels. We found here that the
capacity of CTx to increase cellular cAMP was reduced under
Syn5 and Syn16 RNAi conditions (Fig. 6C), consistent with
the need for a step, mediated by these syntaxins, to gain
cytosolic entry. The combined use of Syn5-Syn16 RNAi had
only a slight additive effect.
Ricin is another toxin known to follow the retrograde route
to ER (Sandvig and van Deurs, 1999). Like STx, ricin is a
ribosome-inactivating protein catalyzing the same depurination
of 28S rRNA (Endo et al., 1987; Endo et al., 1988). The IC50
was shifted from 0.2 ng/ml in control cells to 1.5 ng/ml in
Syn16 RNAi cells (Fig. 6D), resulting in a 7.5-fold protection
against the toxin. The consequence of Syn5 and GS15
knockdowns were very similar and close to that observed with
Syn16. Indeed, the protection against this toxin was 4.5-fold
and threefold with Syn5 and GS15 RNAi, respectively (Fig.
7D). We therefore conclude that Syn5 and Syn16 RNAi
inhibited the action of all three toxins by interfering with their
productive trafficking to the ER. Surprisingly, the protective
effect was particularly striking in the combination of Syn5
RNAi and STx.
One possible explanation for this difference is the
displacement under Syn5 RNAi conditions of a factor
specifically required for the processing of the A-subunit of STx
to A1 and A2 fragments, thus explaining the selective effect on
only this toxin. To test this hypothesis, inhibition of protein
biosynthesis in mock-transfected and Syn5-RNAi-treated cells
was compared for untreated STx and a pre-nicked version
thereof (Fig. 6E). However, because no difference between the
toxin preparations was detected, we exclude this possibility.
Discussion
The list of proteins and lipids that escape the endocytic
pathway for targeting to TGN/Golgi membranes is increasing,
but it is currently unclear how many pathways exist to link the
endocytic and the biosynthetic/secretory routes, and whether
different cargo proteins all use the same molecular machinery
for trafficking across the endosomes-TGN/Golgi interface. In
this study, we have adopted the sulfation test methodology
(Johannes et al., 1997; Mallard and Johannes, 2003) to study
retrograde transport of several exogenous and endogenous
proteins. We observed that down-modulating the expression of
Journal of Cell Science 120 (8)
Fig. 5. Co-distribution analysis of STxB and CTxB. (A,B) Immunofluorescence analysis of STxB (red) and CTxB (green) distribution in (A)
Syn16 RNAi or (B) Syn5 RNAi cells after internalization for 45 minutes at 37°C. (C) Competition analysis. Iodinated STxB was incubated
with HeLa cells in the presence of increasing concentrations of non-labeled CTxB or STxB. The amount of cell-associated radioactivity under
each condition was determined. Note that CTxB did not displace the iodinated STxB from its receptor. (D) Binding analysis. HeLa cells were
incubated on ice with 1 M Alexa Fluor-488-labeled CTxB and 1 M Cy3-labeled STxB. The cells were washed and fixed, and numbers of
cells positive for one or the other marker were counted. Double-positive cells are roughly present at numbers as expected if GM1 and Gb3
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Syn16 and Syn5 inhibited retrograde transport and the
productive intoxication by three protein toxins, STx, CTx and
ricin, and the retrograde transport of MPR. The protective
effect against STx action was much stronger with Syn5 RNAi
than with RNAi targeting Syn16 or the Syn5 SNARE complex
partner GS15, and the Syn5 RNAi effect was more pronounced
against STx than on cells challenged with CTx or ricin. This
points to an as-yet-unidentified STx-specific function of this
SNARE in steps downstream of initial delivery to the ER
lumen.
Cargo proteins in the retrograde route
Based on the experiments described in this study, we conclude
that several exogenous and endogenous cargo proteins share
with STxB the elements of retrograde transport machinery for
their efficient trafficking between endosomes and the
TGN/Golgi. Until now, very few studies have been designed to
address this question directly. To a large extent, this was due
to the fact that molecular inhibitors of the retrograde route and
quantitative tools for its analysis have only become available
relatively recently. The first quantitative tools to assess
membrane traffic between endosomes and TGN/Golgi
membranes were based on the endogenous protein MPR (Goda
and Pfeffer, 1988), and the exogenous STxB and ricin
(Johannes et al., 1997; Rapak et al., 1997). It is therefore not
surprising that most of the available comparative data were
obtained with these proteins.
MPR trafficking studies allowed identification of Rab9
(Lombardi et al., 1993) and TIP47 (Diaz and Pfeffer, 1998) as
molecular players at the interface between late endosomes and
the TGN. More recently, it has been found that MPR can also
use the EE/RE-to-TGN pathway regulated by Syn16/Rab6a
(Saint-Pol et al., 2004). Other studies showed that the capacity
of the ER-routed Pseudomonas exotoxin A to intoxicate cells
was sensitive to Rab9 RNAi (Smith et al., 2006b), whereas
Rab9 did not appear to function in the cell entry of ricin
(Iversen et al., 2001; Simpson et al., 1995). The exact interplay
between the pathways of Syn16-Rab6a and TIP47-Rab9 still
remains to be established.
A comparison of ricin and STxB reveals both differences
and similarities in their trafficking between endosomes and
TGN/Golgi membranes. The most notable difference was the
observation that clathrin is required for retrograde transport of
Fig. 6. Syn5 and Syn16 RNAi effects on cell intoxication by STx,
CTx and ricin. (A) Mock-transfected control cells or HeLa cells
transfected with the indicated siRNAs were treated for 1 hour at
37°C with the indicated doses of STx. Protein biosynthesis was then
determined by measuring the incorporation of radiolabeled
methionine into acid-precipitable material. Data are presented as
percentage of protein biosynthesis under the indicated conditions
when compared with non-toxin-treated cells. (B) Cells were treated
for 1 hour with the indicated doses of STx and analyzed as described
in A. (C) Mock-transfected or RNAi-transfetced cells were treated
with increasing doses of CTx, and cAMP production was measured
to detect CTx arrival in the cytosol. (D) Mock-transfected or RNAi-
transfetced cells were treated for 1 hour with the indicated doses of
ricin, and analyzed as described in A. (E) Intoxication of HeLa cells
by un-nicked (STx) or pre-nicked STx (Nicked) in mock-transfected
control cells or Syn5 RNAi cells (siSyn5). Pre-nicking did not alter
the Syn5-RNAi-mediated protection of cells against the toxin.













STxB (Lauvrak et al., 2004; Saint-Pol et al., 2004) but not for
that of ricin (Iversen et al., 2001). Similarly, changes in calcium
homeostasis affected ricin but not STx (Lauvrak et al., 2002).
However, for both toxins, interfering with the integrity of
membrane domains of the raft type prevented retrograde
transport (Falguières et al., 2001; Grimmer et al., 2000). It was
also found that for both ricin and STx, overexpression of wild-
type Rab11 or expression of a dominant-negative Rab11
mutant moderately inhibited retrograde transport (Iversen et
al., 2001; Wilcke et al., 2000). Taken together with our results,
which show partial protection of cells against ricin and STx
intoxication under conditions of Syn5 and Syn16 knockdown,
we suggest that both toxins share a common mechanism
for targeting TGN/Golgi membranes. However, clathrin-
dependent or not, they may rely on different retrograde sorting
machinery on EE/RE.
For CTxB, quantitative biochemical tools to study retrograde
transport have only recently become available (Fujinaga et al.,
2003) (this study). Before this, it had been noticed that CTxB
and STxB have very similar structures but that their binding to
their glycosphingolipid receptors – GM1 for CTxB and Gb3
for STxB – appears to follow different rules. Indeed, whereas
for STxB, the affinity for one globotriose carbohydrate
molecule is extremely weak (Kd values in the mM range),
CTxB has M affinity for its carbohydrate receptor in solution
(for a review see Pina and Johannes, 2005). Cell-surface-
binding studies have shown that stimulating the uptake of one
toxin receptor, i.e. GM1 or Gb3, does not affect the presence
at the cell surface of the reciprocal receptor (Schapiro et al.,
1998). Despite this, both toxins share the characteristic of
interacting with membrane microdomains of the raft type
(Falguières et al., 2001; Katagiri et al., 1999; Kovbasnjuk et
al., 2001), and fluorescence resonance energy transfer studies
have indicated that both toxins can be very close together after
binding to the plasma membrane (Kovbasnjuk et al., 2001).
Once inside the cell, whether by clathrin-dependent or -
independent endocytosis (Kirkham et al., 2005; Lauvrak et al.,
2004; Saint-Pol et al., 2004; Sandvig et al., 1989), CTxB and
STxB both depend on golgin-97 (Lu et al., 2004), and Syn5
and/or Syn16 (this study) functions to reach TGN/Golgi
membranes.
Later steps of retrograde transport
Considering the established involvement of the Syn5 SNARE
in membrane exchange between the ER and Golgi complex
(Dascher et al., 1994; Hay et al., 1997), the description of Syn5
function at the EE/RE-TGN interface (Tai et al., 2004) came
as a surprise. One possibility was that Syn5 may function in
retrograde transport at several levels of the retrograde route,
e.g. at the EE/RE-TGN interface and at the Golgi-ER interface.
However, the observations reported in our current study clearly
demonstrate that once STxB has reached TGN/Golgi
membranes, Syn5 RNAi does not have an effect on further
retrograde transport to the ER. This suggests that, within the
retrograde pathway, Syn5 function is restricted to the EE/RE-
TGN interface.
Surprisingly, however, although Syn5 RNAi had no effect on
toxin trafficking beyond the EE/RE-to-TGN step, it
significantly protected cells against STx action, considerably
more (~100-fold) than against ricin or CTx. STx and ricin have
the same catalytic mechanism (Endo et al., 1987; Endo et al.,
1988), and our studies show that STxB transport to the ER is
not inhibited more in Syn5 RNAi cells than in Syn16-RNAi-
or GS15-RNAi-transfected cells. Therefore, the STx-specific
effect of Syn5 RNAi most likely resides at the level of the ER.
Whether this effect is direct, such as a role of Syn5 in retro-
translocation or in the distribution of Shiga toxin receptors
within ER microdomains (Smith et al., 2006a), or indirect,
such as a requirement for ER-Golgi cycling prior to
retrotranslocation, remains to be determined in later studies. In
conclusion, we have shown that several exogenous and
endogenous cargo proteins share the same protein machinery
for efficient retrograde transport at the EE/RE-TGN interface,
which suggests the existence of limited molecular redundancy
for targeting the TGN/Golgi from endosomes.
Materials and Methods
Materials, recombinant proteins and antibodies
Monoclonal antibody anti-CTR433 was from M. Bornens (Institut Curie, Paris,
France), and polyclonal antibodies against Syn16 and Syn5 were from W. Hong
(IMCB, Singapore). Monoclonal antibodies against TfR (Sigma), GFP (Roche),
clathrin heavy chain, -adaptin, GS15 (all BD Biosciences), polyclonal antibodies
against Syn7 (Synaptic Systems), and FITC-, Cy3- and Cy5-coupled secondary
antibodies (Jackson Immuno-research) were purchased from the indicated suppliers.
STxB-FITC, CTxB-Cy3, STxB-Sulf2 and monoclonal anti-STxB antibody 13C4
were prepared as previously described (Johannes et al., 1997; Mallard et al., 1998).
Cells
HeLa cells were cultured as described (Johannes et al., 1997). HeLa cells stably
transfected with GFP-MPR300 were from B. Hoflack (Universität Dresden,
Germany) and were grown in the presence of 0.5 mg/ml of Geneticin (G418).
RNA interference
Three synthetic siRNA duplex oligomers (21-mers) targeting human syntaxin 16
(first: ACAGCUUCACAAGGCAGAA; second: GGACCUUUGAUACUGCUGC;
third: GCAGCGAUUGGUGUGACAA), two 21-mers targeting human syntaxin 5
(first: AAGTGAGGACAGAGAACCTGA; second: AAAGGAAGCGTTGGCA -
GC AAA), two siRNA targeting syntaxin 7 (first: ACTTCCAGAAGGTCC A -
GAGTT; second: GTTTTGGGCCACATTGCATT), and one scrambled siRNA
(GACAAGAACCAGAACGCCATT) were designed and then ordered from a
commercial supplier (MWG-Biotech, Germany). Cells were transfected using
oligofectAMINE (Invitrogen) according to the manufacturer’s instructions.
Experiments were carried out 3 days after transfection. Except for experiments
described in Fig. 1, concentrations of 200 nM of siRNA were used for transfection.
Imunofluorescence analysis
Immunofluorescence analysis was performed as previously described (Mallard et
al., 1998). Briefly, cells were incubated with 1 M STxB-FITC, STxB-Cy3 or
CTxB-Cy3 for 30 minutes at 4°C, shifted to 37°C for 45 minutes, fixed in 4%
paraformaldehyde and permeabilized with saponin. After labeling with the indicated
antibodies, coverslips were mounted and analyzed by confocal microscopy (Leica
Microsystems, Mannheim, Germany).
Chemical coupling
For the coupling of sulfation-site peptide to CTxB or anti-GFP antibody, the
following procedure was performed as described (Amessou et al., 2006). Briefly,
CTxB or anti-GFP antibody (50 to 100 M in 50 mM sodium phosphate buffer, 1
mM EDTA, pH 7.5) were incubated at room temperature for 30 minutes with 0.8-
1.5 mM SATA reagent (N-Succinimidyl-S-acetylthioacetate; Pierce). Activated
molecules were then incubated for 2 hours at room temperature with bromo-
acetylated sulfation-site peptide (Neosystem, Strasbourg, France) in the presence of
500 mM hydroxylamine. The coupling reaction was then stopped by dialysis against
PBS buffer.
Sulfation analysis
Sulfation analysis was performed as described before (Mallard et al., 1998). When
two cargo proteins were analyzed, the following modifications were used. 1 M of
STxB-Sulf2 were simultaneously incubated with HeLa cells in the presence of 1
M of CTxB-Sulf2 or 15 g/ml of anti-GFP-Sulf2 antibody. After uptake in the
presence of 0.4 mCi/ml radioactive sulfate (Amersham), cells were lysed in PBS,
1% Triton X-100 and protease-inhibitor cocktail, and centrifuged for 10 minutes at
3000 g to remove the nuclei. 10% of the supernatant was immunprecipitated with
monoclonal anti-STxB antibody (13C4), whereas 90% of the supernatant were
precipitated with either streptavidine-agarose (CTxB-Sulf2) or with protein G-
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Sepharose (anti-GFP-Sulf2 antibody). Sulfated cargos were analyzed by SDS-PAGE
autoradiography. In parallel, the sulfation of endogenous proteins and proteoglycans
was determined by TCA-precipitation from immunopreciptation supernatants and
used to normalize data obtained when studying toxin sulfation in various conditions.
Total sulfation counts are usually similar in all conditions, except for Syn5 RNAi
(see Fig. 2C).
Glycosylation analysis
Glycosylation analysis and tunicamycin treatment were performed as previously
described (Johannes et al., 1997; Mallard et al., 1998).
Cytotoxicity assays
STx, DTx and ricin cytotoxicities were measured by the ability of cells to
incorporate [35S]-methionine into acid-precipitable material following toxin
treatment. HeLa cells were seeded at 1.5104 cells per well into flat-bottomed 96-
well plates and grown overnight. Cells were then overlaid with medium containing
appropriate concentrations of toxin for 60 minutes. Remaining cellular protein
synthesis following toxin treatment was determined from the incorporation of a 60-
minute pulse of 1 Ci [35S]-methionine per well into total protein. Plates were then
washed three times with ice-cold 5% TCA to precipitate proteins. After two more
washes in PBS, radioactivity was counted in Wallac Optiphase Supermix. For
measuring CTx-induced cAMP production, cells were detached with 2 mM EDTA
in PBS and incubated with indicated concentrations of CTx for 2 hours at 37°C.
After lysis in 0.1 M HCl, intracellular cAMP levels were assayed using the Direct
cAMP Enzyme Immunoassay kit (Sigma).
STxB- and Tf-internalization assays
STxB-K3 (STxB variant with three C-terminal lysines) and human diferric
transferrin were biotinylated using NHS-SS-biotin following manufacturer’s
instructions (Pierce). Endocytosis was measured as described recently (Amessou et
al., 2006). Briefly, serum-starved cells were detached from plates with 2 mM EDTA
in PBS and incubated in the presence of 1 M biotin-STxB and 200 nM biotin-Tf
for 30 minutes on ice. After washing, cells were incubated at 37°C for the indicated
times (1.5105 cells per data point). The remaining biotin on cell-surface-exposed
STxB or transferrin was cleaved by subsequent treatment with 100 mM of the non-
membrane permeable reducing agent sodium 2-mercaptoethanesulfonic acid
(MESNA) on ice for 20 minutes. After washing, excess MESNA was quenched with
100 mM iodoacetamide for 20 minutes. Cells were lysed in blocking buffer (10 mM
Tris [pH 7.4], 1 mM EDTA, 50 mM NaCl, 0.2% BSA, 0.1% SDS, and 1% Triton
X-100) before loading on ELISA plates coated either with anti-Tf or anti-STxB
antibody (13C4). Biotinylated STxB or transferrin was detected using streptavidin-
HRP (Roche). The reaction was stopped with 3 M sulphuric acid and the plate was
read at 490 nm. The percentage of internal STxB (or Tf) was determined as the ratio
of signal after MESNA reduction (internal ligand) to signal without reduction (total
ligand).
EGF-degradation and Tf-recycling assays
The assays were performed as described previously (Mallard et al., 1998; Saint-Pol
et al., 2004). Briefly, HeLa cells were serum-starved and incubated for 30 minutes
on ice with iodinated EGF (750 Ci/mmol; Amersham Life Sciences). Cells were
washed, shifted to 37°C for the indicated times, and put back on ice. TCA-soluble
counts from cells and culture medium were expressed as percentage of total cell-
associated radioactivity.
VSVG-GFP anterograde transport assay
Cells were transfected with ts045-VSVG-GFPct plasmid DNA (Scales et al., 1997).
Transfection was carried out with Calcium Phosphate Transfection Kit (Invitrogen)
using 5 g of plasmid per transfection. After transfection, cells were incubated at
40°C for 20 hours. The cells were then detached from plates with 20 mM EDTA in
PBS, washed in PBS++ (PBS containing 0.1 mM CaCl2 and 0.1 mM MgCl2, pH
7.4) and pre-incubated or not with 5 g/ml BFA at 40°C. Cells were then incubated
for 2 hours at 32°C or put on ice. Surface proteins were biotinylated with 2.5 mg/ml
NHS-SS-biotin in PBS containing Ca2+ and Mg2+ for 10 minutes on ice. The
reaction was quenched with 50 mM NH4Cl for 10 minutes on ice, the cells were
lysed in buffer containing 1% Triton X-100, 0.1% SDS, 0.2% BSA, 50 mM NaCl,
1 mM EDTA, 10 mM Tris pH 7.4. Cell lysates were divided in two, transferred to
96-well ELISA plates coated with anti-VSVG antibody, and revealed by ELISA for
anti-HRP-streptavidin antibody (cell surface VSVG) or anti-GFP antibody (total
VSVG protein). The latter was used for normalization.
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